T-cell promoter data presented at CGTI Leadership Summit

Our Chief Strategy Officer Martijn Kelder will be speaking at the Cell and Gene Therapy Innovation Leadership Summit in Barcelona, next Thursday at 15:15. His presentation will reveal Annogen’s latest developments in promoter discovery and characterization, revealing novel data on our validated T-cell specific promoters for in vivo CAR-T cell therapies now available for licensing. We will also announce our upcoming partnership with Lentitek on validating these promoters. CGTI 2025 brings together senior leaders to address the patient-impacting challenges of intelligent manufacturing, connected processes and real-world translation in a curated in-person setting.